Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells

Recent evidence suggests that glutamate signaling plays an important role in cancer. Riluzole is a glutamate release inhibitor and FDA-approved drug for the treatment of amyotrophic lateral sclerosis. It has been investigated as an inhibitor of cancer cell growth and tumorigenesis with the intention...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Dolfi, Sonia C, Medina, Daniel J, Kareddula, Aparna, Paratala, Bhavna, Rose, Ashley, Dhami, Jatinder, Chen, Suzie, Ganesan, Shridar, Mackay, Gillian, Vazquez, Alexei, Hirshfield, Kim M
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2017
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546507/
https://ncbi.nlm.nih.gov/pubmed/28591718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17961
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker